Home | | Clinical Cases in Anesthesia | How is preeclampsia prevented from degenerating into eclampsia?

Chapter: Clinical Cases in Anesthesia : Preeclampsia

How is preeclampsia prevented from degenerating into eclampsia?

Magnesium sulfate (MgSO4), a central nervous system depressant and anticonvulsant, is the first-line drug in the United States for the prevention of eclampsia.

How is preeclampsia prevented from degenerating into eclampsia?

 

Magnesium sulfate (MgSO4), a central nervous system depressant and anticonvulsant, is the first-line drug in the United States for the prevention of eclampsia. One of the many sites of action of MgSO4 is at the myoneural junction.

The decrease in hyperreflexia seen with the administration of MgSO4 is secondary to the inhibition of acetylcholine release at the neuromuscular junction, decreased sensitivity of the motor endplate to acetylcholine, and the decreased excitability of the muscle membrane. MgSO4 is also a mild vasodilator and decreases uterine hyperactivity, which results in an increase in uterine blood flow. It also causes vasodilation at the renal and liver beds thus improving their function.

 

Therapeutic levels of magnesium are between 4 and 8 mEq/L. Above this level, magnesium has both maternal and neonatal side-effects. Magnesium can lead to elec-trocardiographic changes and ultimately cardiac and respiratory arrest. These severe side-effects, however, do not occur until after the loss of deep tendon reflexes (Table 60.2). Therefore, by monitoring serum magnesium levels and deep tendon reflexes catastrophic side-effects may be avoided. Magnesium, because of its actions at the neuromuscular junction, increases the sensitivity of the mother to both depolarizing and nondepolarizing muscle relaxants.


Since magnesium crosses the placenta, the neonate can also exhibit signs of magnesium toxicity. Signs of magne-sium toxicity in the newborn include respiratory depression, apnea, and decreased muscle tone. Magnesium toxicity in the newborn and the mother can be reversed with the administration of calcium.


 

MgSO4 is administered intravenously with a loading dose of 2–4 grams over 15 minutes, followed by an infusion of 1–3 grams per hour. MgSO4 is primarily excreted by the kidneys. Therefore, renal function must be carefully moni-tored and the magnesium dose decreased accordingly in the face of renal insufficiency.

 

Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Clinical Cases in Anesthesia : Preeclampsia : How is preeclampsia prevented from degenerating into eclampsia? |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.